Title:
アイドルモード無線測定改良
Document Type and Number:
Japanese Patent JP7247214
Kind Code:
B2
Abstract:
There is provided a method at a user equipment, comprising: determining a first cell to connect with; determining capabilities of the user equipment in relation to carrier aggregation comprising a carrier of the first cell; performing idle mode radio measurements of those carriers that the user equipment can, based on the determined capabilities, aggregate with the carrier of the first cell; and reporting results of the idle mode radio measurements to a network node of the first cell upon connection establishment with the first cell.
More Like This:
Inventors:
Darth God Rash
henttonen terror
Wilte Elena
henttonen terror
Wilte Elena
Application Number:
JP2020554503A
Publication Date:
March 28, 2023
Filing Date:
March 26, 2019
Export Citation:
Assignee:
Nokia Technologies O You
International Classes:
H04W8/22; H04W24/10; H04W72/0457; H04W76/15
Foreign References:
| WO2017213222A1 |
Other References:
Qualcomm Incorporated,Fast SCell Configuration and Activation Through network assisted RRC_Idle mode measurements,3GPP TSG RAN WG2 #99 R2-1707788,2017年08月11日,
Nokia, Nokia Shanghai Bell,Details of IDLE mode measurements (IDLE mode),3GPP TSG RAN WG2 #100 R2-1713161,2017年11月20日,
Qualcomm Incorporated,Fast SCell Configuration through Quick SCell Measurement Reporting,3GPP TSG RAN WG2 #101 R2-1802073,2018年02月15日,
Nokia, Nokia Shanghai Bell,Details of IDLE mode measurements (IDLE mode),3GPP TSG RAN WG2 #100 R2-1713161,2017年11月20日,
Qualcomm Incorporated,Fast SCell Configuration through Quick SCell Measurement Reporting,3GPP TSG RAN WG2 #101 R2-1802073,2018年02月15日,
Attorney, Agent or Firm:
Mitsunori Kawamorida
Previous Patent: debug controller circuit
Next Patent: THERAPEUTIC AGENT AGAINST GRANULOMATOUS AND FIBROMATOUS LUNG DISEASE
Next Patent: THERAPEUTIC AGENT AGAINST GRANULOMATOUS AND FIBROMATOUS LUNG DISEASE